How many studies have been conducted on Terlipressin?

BiohacksAI has indexed 300 PubMed studies on Terlipressin, including 50 randomized controlled trials (RCTs). 69% of studies involve human subjects.

What are the main research areas for Terlipressin?

The primary research domains for Terlipressin are 🫘 Kidney, 🫁 Liver & Detox, 🦠 Gut & Microbiome. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Terlipressin

An inactive peptide prodrug that is slowly converted in the body to lypressin. It is used to control bleeding of ESOPHAGEAL VARICES and for the treatment of HEPATORENAL SYNDROME.

300+ PubMed studies analyzed · 50 RCTs · Evidence Score: 57

Research Domains

Terlipressin has been studied across 10 research domains including 🫘 Kidney, 🫁 Liver & Detox, 🦠 Gut & Microbiome, 🧠 Focus & Attention, ❤️ Cardiovascular. The primary research focus is 🫘 Kidney with 49% of studies addressing this area.

Loading evidence profile...

This evidence profile for Terlipressin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.